Reckitt Benckiser Group plc (LON:RKT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is GBX 6,204.29.
Several research analysts have recently issued reports on RKT shares. Deutsche Bank Aktiengesellschaft decreased their price target on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating for the company in a research note on Tuesday, April 28th. Royal Bank Of Canada reaffirmed a “neutral” rating and set a GBX 6,200 target price on shares of Reckitt Benckiser Group in a research note on Friday, May 15th. Citigroup decreased their target price on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research note on Thursday, April 23rd. Jefferies Financial Group reaffirmed a “hold” rating and set a GBX 5,600 target price on shares of Reckitt Benckiser Group in a research note on Tuesday, May 12th. Finally, Berenberg Bank decreased their target price on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating for the company in a research note on Friday, April 24th.
Get Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Performance
Reckitt Benckiser Group (LON:RKT – Get Free Report) last issued its quarterly earnings data on Thursday, March 5th. The company reported £122.58 EPS for the quarter. Reckitt Benckiser Group had a return on equity of 38.45% and a net margin of 25.23%. As a group, equities research analysts predict that Reckitt Benckiser Group will post 331.2110727 EPS for the current year.
Insiders Place Their Bets
In other news, insider Kris Licht sold 5,435 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of GBX 4,753, for a total transaction of £258,325.55. 0.44% of the stock is owned by corporate insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
